The global cancer burden is growing. Over 35 million new cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. This is reflected in cancer-related health claims within the general healthcare system, which are increasing in both frequency and cost. Based on a study of medical claims data from 43 countries, the number of cancer claims grew by 184% from 2019 to 2023 – and cancer-related claims costs grew by 242%.
In workers’ compensation, cancer claims can be a significant driver of medical costs, including pharmacy costs, for payers with these claims in their covered populations. According to Healthesystems’ annual survey of workers’ comp stakeholders, slightly more than half of participants said that complex/high-dollar claims are a major challenge.
Where do we typically see these claims in workers’ comp, and how do prescription drug costs play a role in the economic impact of cancer?
Occupational Cancer: By the Numbers
- 2-8% of all cancers are caused by exposures to workplace carcinogens
- 1 in 5 workers may be at an elevated risk for contracting cancer
- 40% of worldwide cancer deaths could be prevented by efforts to reduce workplace toxins
- 54%-75% of occupational cancers are lung cancer
